NZ239935A - Substituted 4-amino pyridine derivatives and pharmaceutical compositions - Google Patents

Substituted 4-amino pyridine derivatives and pharmaceutical compositions

Info

Publication number
NZ239935A
NZ239935A NZ239935A NZ23993591A NZ239935A NZ 239935 A NZ239935 A NZ 239935A NZ 239935 A NZ239935 A NZ 239935A NZ 23993591 A NZ23993591 A NZ 23993591A NZ 239935 A NZ239935 A NZ 239935A
Authority
NZ
New Zealand
Prior art keywords
compound
hydrogen
loweralkyl
formula
pyridinol
Prior art date
Application number
NZ239935A
Other languages
English (en)
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Nicholas Joseph Hrib
John Gerard Jurcak
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NZ239935A publication Critical patent/NZ239935A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surface Treatment Of Glass (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ239935A 1990-09-27 1991-09-25 Substituted 4-amino pyridine derivatives and pharmaceutical compositions NZ239935A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
NZ239935A true NZ239935A (en) 1995-07-26

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ239935A NZ239935A (en) 1990-09-27 1991-09-25 Substituted 4-amino pyridine derivatives and pharmaceutical compositions

Country Status (22)

Country Link
US (3) US5821239A (en:Method)
EP (1) EP0477903B1 (en:Method)
JP (1) JP3090511B2 (en:Method)
KR (1) KR100215357B1 (en:Method)
AT (1) ATE136297T1 (en:Method)
AU (1) AU637720B2 (en:Method)
CA (1) CA2052433C (en:Method)
CZ (1) CZ282002B6 (en:Method)
DE (1) DE69118470T2 (en:Method)
DK (1) DK0477903T3 (en:Method)
ES (1) ES2085940T3 (en:Method)
FI (1) FI914504A7 (en:Method)
GR (1) GR3019742T3 (en:Method)
HU (1) HUT60247A (en:Method)
IE (1) IE73874B1 (en:Method)
IL (1) IL99581A (en:Method)
NO (1) NO913778L (en:Method)
NZ (1) NZ239935A (en:Method)
PT (1) PT99073B (en:Method)
TW (1) TW200462B (en:Method)
YU (1) YU158591A (en:Method)
ZA (1) ZA917692B (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
CZ2004714A3 (cs) * 2001-12-14 2004-10-13 Novoánordiskáa@S Sloučeniny a jejich použití ke snížení aktivity lipázy citlivé vůči hormonu
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
PL2607362T3 (pl) * 2005-02-17 2015-05-29 Astellas Pharma Inc Karboksylany piperydyny i piperazyny jako inhibitory FAAH
JP2012502103A (ja) * 2008-09-10 2012-01-26 アクオルダ セラピューティクス，インコーポレーテッド 持効性アミノピリジン組成物を使用する方法
EA202092673A3 (ru) 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
RU2635528C2 (ru) 2012-12-13 2017-11-13 Х. Лундбекк А/С Композиции, содержащие вортиоксетин и донепезил
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US4831044A (en) * 1987-10-29 1989-05-16 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
US4994473A (en) * 1987-11-17 1991-02-19 Ici Americas Inc. Pyridyl containing insecticides
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
KR0156241B1 (ko) * 1988-11-16 1998-11-16 도날드 알.토센 하이드록시-1,2,3,4-테트라하이드로아미노아크리딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
JP3090511B2 (ja) 2000-09-25
FI914504A0 (fi) 1991-09-25
NO913778L (no) 1992-03-30
HUT60247A (en) 1992-08-28
ES2085940T3 (es) 1996-06-16
US5821239A (en) 1998-10-13
HU913075D0 (en) 1992-01-28
US5869480A (en) 1999-02-09
DK0477903T3 (da) 1996-07-29
YU158591A (sh) 1994-12-28
ZA917692B (en) 1992-05-27
IL99581A (en) 1995-07-31
ATE136297T1 (de) 1996-04-15
KR100215357B1 (ko) 1999-08-16
TW200462B (en:Method) 1993-02-21
EP0477903A2 (en) 1992-04-01
CZ282002B6 (cs) 1997-04-16
US5866565A (en) 1999-02-02
DE69118470T2 (de) 1996-09-19
IE73874B1 (en) 1997-07-02
CA2052433C (en) 2003-04-15
FI914504A7 (fi) 1992-03-28
EP0477903A3 (en) 1992-08-05
CA2052433A1 (en) 1992-03-28
PT99073A (pt) 1992-08-31
KR920006318A (ko) 1992-04-27
NO913778D0 (no) 1991-09-26
CS293691A3 (en) 1992-04-15
JPH04261157A (ja) 1992-09-17
AU8475691A (en) 1992-04-02
PT99073B (pt) 1999-02-26
EP0477903B1 (en) 1996-04-03
IL99581A0 (en) 1992-08-18
IE913389A1 (en) 1992-04-08
DE69118470D1 (de) 1996-05-09
AU637720B2 (en) 1993-06-03
GR3019742T3 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
US5708007A (en) 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) benzofuran-7-ol and carbamate derivatives for treating memory dysfunction
NZ239935A (en) Substituted 4-amino pyridine derivatives and pharmaceutical compositions
CA2354606C (en) Azabicycloalkane derivatives and therapeutic uses thereof
EP0468401B1 (en) 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments
US5100891A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
JP2961013B2 (ja) 〔（アリールアルキルピペリジン−４−イル）メチル〕−２ａ，３，４，５−テトラヒドロ−１（２Ｈ）−アセナフチレン−１−オン類および関連化合物
EP0535645B1 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones and 3-amino-1-hydroxypyrrolidin-2-ones, a process for their preparation and their use as medicaments
AU643135B2 (en) 1-(pyrido(3,4.b)-1,4-oxazinyl-4-YL)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments
NZ545917A (en) Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
JP2001511799A (ja) オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物
US5091541A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US4983616A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5472975A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds
US5192789A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds
US4920117A (en) 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use
NZ260210A (en) Pyrrolo[2,3-b]indole acetic acids and pharmaceutical compositions
US4942237A (en) Method of preparing isoxazolo(5,4,3-kl)acridines